Fields »
ABOUT
HELP
BLOG

552 GENES FOUND

Show / hide columns

XML | RDF | TSV | Page of 12 | next »

Gene

 

 

Gene description

x

 

 

 

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

IH abundance (Normal Tissue)

x

RNA abundance (Normal Tissue)

x

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

RNA TS

x

RNA TS TPM

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 
ABCA13ATP-binding cassette, sub-family A (ABC1), member 13
Vesicles
Centrosome
Cytosol		Tissue enriched10bone marrow:29.4
ABCB7ATP-binding cassette, sub-family B (MDR/TAP), member 7
MitochondriaRenal cancer: 5.31e-6
Expressed in all
ABCB8ATP-binding cassette, sub-family B (MDR/TAP), member 8
Nucleus
Mitochondria		Pancreatic cancer: 3.34e-4
Renal cancer: 5.88e-4
Head and neck cancer: 5.91e-4
Expressed in all
ABCB9ATP-binding cassette, sub-family B (MDR/TAP), member 9
VesiclesGlioma: 4.62e-4
Tissue enhancedtestis:23.9
ABCG1ATP-binding cassette, sub-family G (WHITE), member 1
Golgi apparatus
Vesicles		Renal cancer: 7.16e-6
Expressed in all
ABCG4ATP-binding cassette, sub-family G (WHITE), member 4N/A
Group enriched6cerebral cortex:6.6
parathyroid gland:4.0
testis:5.1
ABCG8ATP-binding cassette, sub-family G (WHITE), member 8
VesiclesGroup enriched25duodenum:51.4
liver:34.1
small intestine:56.7
AC171558.1N/A
CentrosomeTissue enriched11testis:4.3
AC171558.2
Tissue enriched26testis:2.5
ACKR1Atypical chemokine receptor 1 (Duffy blood group)
Cervical cancer: 2.52e-5
Liver cancer: 1.48e-4
Thyroid cancer: 9.76e-4
Mixed
ACKR2Atypical chemokine receptor 2
Nucleoplasm
Vesicles
Cytosol		Tissue enhancedplacenta:22.8
ACKR3Atypical chemokine receptor 3
Vesicles
Plasma membrane		Renal cancer: 1.76e-6
Stomach cancer: 2.01e-4
Urothelial cancer: 2.93e-4
Cervical cancer: 4.64e-4
Expressed in all
ACKR4Atypical chemokine receptor 4
CytosolMixed
ADCY5Adenylate cyclase 5N/A
Intermediate filamentsRenal cancer: 7.46e-6
Tissue enhancedheart muscle:72.9
ADCYAP1R1Adenylate cyclase activating polypeptide 1 (pituitary) receptor type I
VesiclesEndometrial cancer: 5.78e-4
Tissue enhancedcerebral cortex:137.5
fallopian tube:46.5
ADGRA1Adhesion G protein-coupled receptor A1
Tissue enhancedadrenal gland:4.9
cerebral cortex:22.5
ADGRA2Adhesion G protein-coupled receptor A2N/A
Renal cancer: 3.18e-7
Expressed in all
ADGRA3Adhesion G protein-coupled receptor A3
Expressed in all
ADGRB2Adhesion G protein-coupled receptor B2
CentrosomeLung cancer: 4.02e-5
Breast cancer: 6.46e-4
Tissue enriched14cerebral cortex:72.5
ADGRD1Adhesion G protein-coupled receptor D1
Nucleus
Cytosol		Liver cancer: 9.27e-4
Tissue enhancedplacenta:44.3
ADGRE1Adhesion G protein-coupled receptor E1
Tissue enhancedappendix:10.2
spleen:20.1
ADGRE2Adhesion G protein-coupled receptor E2
VesiclesRenal cancer: 4.35e-6
Tissue enhancedappendix:27.6
spleen:15.7
ADGRE3Adhesion G protein-coupled receptor E3N/A
Tissue enhancedappendix:8.9
spleen:8.8
ADGRE5Adhesion G protein-coupled receptor E5
CytosolRenal cancer: 1.87e-6
Liver cancer: 3.73e-5
Expressed in all
ADGRF1Adhesion G protein-coupled receptor F1
Renal cancer: 1.35e-5
Tissue enhancedesophagus:14.7
kidney:17.6
urinary bladder:19.6
ADGRF2Adhesion G protein-coupled receptor F2N/A
Tissue enhancedfallopian tube:1.5
skin:1.4
ADGRF3Adhesion G protein-coupled receptor F3N/A
Not detected
ADGRF4Adhesion G protein-coupled receptor F4
MitochondriaPancreatic cancer: 5.52e-4
Group enriched7esophagus:12.1
skin:45.9
ADGRG1Adhesion G protein-coupled receptor G1
Renal cancer: 5.52e-7
Head and neck cancer: 2.53e-4
Expressed in all
ADGRG3Adhesion G protein-coupled receptor G3N/A
Group enriched5appendix:19.4
bone marrow:86.7
ADGRG4Adhesion G protein-coupled receptor G4N/A
Tissue enhancedduodenum:2.6
small intestine:1.7
ADGRG5Adhesion G protein-coupled receptor G5
Nucleoplasm
Nuclear membrane
Vesicles		Cervical cancer: 4.25e-4
Tissue enhancedlymph node:11.3
tonsil:8.9
ADGRG6Adhesion G protein-coupled receptor G6
Pancreatic cancer: 2.78e-5
Lung cancer: 8.78e-4
Tissue enhancedplacenta:66.6
ADGRL1Adhesion G protein-coupled receptor L1
Pancreatic cancer: 1.14e-4
Renal cancer: 4.45e-4
Tissue enhancedcerebral cortex:60.3
ADGRL2Adhesion G protein-coupled receptor L2
Plasma membrane
Cell Junctions		Endometrial cancer: 1.33e-4
Stomach cancer: 3.00e-4
Liver cancer: 9.92e-4
Mixed
ADGRL3Adhesion G protein-coupled receptor L3
Tissue enhancedcerebral cortex:42.1
parathyroid gland:30.1
ADGRL4Adhesion G protein-coupled receptor L4
Renal cancer: 1.60e-4
Mixed
ADGRV1Adhesion G protein-coupled receptor V1
Group enriched6adrenal gland:56.5
cerebral cortex:29.1
ADIPOR2Adiponectin receptor 2
Expressed in all
ADORA1Adenosine A1 receptor
Plasma membraneTissue enhancedcerebral cortex:46.5
testis:23.4
ADORA2BAdenosine A2b receptor
CytosolMixed
ADRA1AAdrenoceptor alpha 1A
Tissue enhancedadipose tissue:22.6
liver:32.0
ADRA1BAdrenoceptor alpha 1B
Plasma membraneRenal cancer: 1.40e-6
Thyroid cancer: 3.19e-5
Endometrial cancer: 6.00e-5
Ovarian cancer: 2.67e-4
Glioma: 6.07e-4
Tissue enhancedcerebral cortex:14.8
spleen:17.3
ADRA1DAdrenoceptor alpha 1DN/A
Tissue enhancedcervix, uterine:4.3
prostate:4.2
ADRA2BAdrenoceptor alpha 2B
Mixed
ADRA2CAdrenoceptor alpha 2CN/A
Tissue enhancedcervix, uterine:21.0
endometrium:26.0
seminal vesicle:26.7
ADRB1Adrenoceptor beta 1
Tissue enhancedplacenta:45.2
ADRB2Adrenoceptor beta 2, surfaceN/A
CytosolRenal cancer: 3.15e-9
Mixed
AGTR1Angiotensin II receptor, type 1
VesiclesTissue enhancedplacenta:212.0
ALG8ALG8, alpha-1,3-glucosyltransferase
NucleoplasmExpressed in all

Page of 12 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.